Antibiotic Prophylaxis for Hysterosalpingography (HSG)
Routine antibiotic prophylaxis is not recommended for standard HSG procedures, but should be given to women with dilated tubes identified during the procedure, using doxycycline as the preferred agent. 1
General Approach
The evidence for antibiotic prophylaxis in HSG is limited and somewhat conflicting, requiring a risk-stratified approach rather than universal coverage.
Standard Risk Patients
- No routine prophylaxis is needed for women undergoing HSG without specific risk factors 1
- The baseline infection risk in low-risk populations is acceptably low (0.3-1.3%) and does not justify universal antibiotic use 2
- This approach aligns with the broader principle that outpatient hysteroscopic procedures do not require routine antibiotic prophylaxis 3
High-Risk Patients Requiring Prophylaxis
Women with dilated fallopian tubes identified at the time of HSG represent the highest risk group and should receive prophylactic antibiotics 1. This finding suggests pre-existing tubal pathology that increases infection susceptibility.
Recommended Antibiotic Regimens
First-Line Agent
- Doxycycline is the preferred prophylactic antibiotic for HSG 4, 1
- In a large retrospective cohort study, doxycycline demonstrated the lowest risk of acute pelvic inflammatory disease (adjusted OR 0.20,95% CI 0.04-0.81) 4
Alternative Agents
- First-generation cephalosporins are an effective alternative (adjusted OR 0.35,95% CI 0.18-0.68) 4
- For patients with β-lactam allergy: clindamycin, erythromycin, or metronidazole can be substituted 1
Evidence Quality and Nuances
The recommendation against routine prophylaxis is based on:
- A large retrospective cohort study (n=7,919) showing prophylaxis reduced acute PID from 1.42% to 0.46% (adjusted OR 0.33), but this benefit must be weighed against universal antibiotic exposure 4
- The 2024 BJOG hysteroscopy guideline showing no benefit from routine prophylaxis in similar intrauterine procedures (1.0% vs 1.3% infection rate, p>0.05) 3
Important caveat: One older study from Kenya reported a 44% post-HSG infection rate, suggesting that in settings with high baseline STI prevalence or endemic pelvic infection, universal prophylaxis may be warranted 5. However, this represents an outlier and likely reflects population-specific factors not generalizable to standard practice.
Clinical Pitfalls to Avoid
- Do not rely on traditional laboratory tests to predict infection risk—they have poor predictive value 2
- Aerobic-only coverage is insufficient in high-risk patients; ensure anaerobic coverage is included 2
- Screen for sexually transmitted infections in high-risk populations before the procedure rather than relying solely on prophylaxis 1
- Consider that many infertile women may harbor quiescent genital tract infections that HSG could reactivate 5